| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 04/17/2001 | US6218431 Substituted biphenyls |
| 04/17/2001 | US6218426 For therapy of mammalian reproductive disorders and steroid hormone-dependent tumors as well as for regulating fertility, where suppression of gonadotropin release is indicated |
| 04/17/2001 | US6218393 Anthranilic acid derivatives as multi drug resistance modulators |
| 04/17/2001 | US6218072 Optical information recording medium |
| 04/17/2001 | CA2158457C Naphthalene derivatives |
| 04/17/2001 | CA2080475C Neuroprotective indolone and related derivatives |
| 04/12/2001 | WO2001025211A1 Method of making metal 8-quinolinolato complexes |
| 04/12/2001 | WO2001025181A1 Carboxylic acid derivatives and drugs containing the same |
| 04/12/2001 | WO2001024785A2 Dihydroorotate dehydrogenase inhibitors for the treatment of viral-mediated diseases |
| 04/12/2001 | WO1999063939A9 Multibinding inhibitors of cyclooxygenase-2 |
| 04/12/2001 | WO1998050343A3 (hetero)aryl carboxamide derivatives, process for their preparation and their use in the treatment of cns disorders |
| 04/11/2001 | EP1090917A1 Quinolin-4-yl derivatives and their use as NMDA-receptor subtype blockers |
| 04/11/2001 | EP1089963A1 Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release |
| 04/11/2001 | EP0936866A4 Compounds, compositions and methods for treating antibiotic-resistant infections |
| 04/11/2001 | EP0847389A4 Process for preparing quinoline bases |
| 04/11/2001 | CN1291216A Azo comounds and process for producing the same |
| 04/11/2001 | CN1291183A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors |
| 04/11/2001 | CN1290698A Quinoline-4-base deviative I |
| 04/11/2001 | CN1064357C Novel antimicrobial 5-(N-heterosubstiluted amino) quinolones and medicinal composition |
| 04/11/2001 | CN1064350C Aryl and heteroaryl alkoxynaphtalene derivatives |
| 04/10/2001 | US6215030 Catalytic reduction of acids, esters and anhydrides to alcohols |
| 04/10/2001 | US6214861 Enzyme inhibitor; viricides |
| 04/10/2001 | US6214835 Dihalopropene compounds insecticides containing them as active ingredients, and intermediates for their production |
| 04/10/2001 | US6214829 Piperazine compounds, their preparation, and methods of using them |
| 04/05/2001 | WO2001023389A2 Certain alkylene diamine-substituted heterocycles |
| 04/04/2001 | EP1088818A1 Quinolin-4-yl derivatives |
| 04/04/2001 | EP1088481A2 Fungicides for the control of take-all disease of plants |
| 04/04/2001 | EP1087937A1 Cyclic hydroxamic acids as metalloproteinase inhibitors |
| 04/04/2001 | EP0710662B1 Quinolinecarboxylic acid derivative |
| 04/04/2001 | EP0636127B1 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity |
| 04/04/2001 | CN1290255A Dihydroxyhexanoic acid derivatives |
| 04/04/2001 | CN1290249A Aminoguanidine hydrazone derivatives, process for producing the same and drugs thereof |
| 04/03/2001 | US6211376 8-hydroxy-7-substituted quinolines as anti-viral agents |
| 04/03/2001 | US6211364 Process for preparing indane-like compounds |
| 04/03/2001 | US6211241 Aryl sulfonamides and sulfamide derivatives and uses thereof |
| 04/03/2001 | US6211240 O-benzyl oxime ether derivatives and their use as pesticides |
| 04/03/2001 | US6211197 Carboxylic acid or tetrazole derivates; analgesics, antipyretics, and antiinflammatory agents; side effect reduction |
| 04/03/2001 | US6211196 Benzyloxy-substituted, fused N-heterocycles, processes for their preparation, and their use as bradykinin receptor antagonists |
| 04/03/2001 | US6211179 Treating sexual disorders, impotency, and menopause; administering purine derivative; nitric oxide synthase substrates |
| 04/03/2001 | US6211176 α- and β-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors |
| 04/03/2001 | CA2012558C Method for the sequential oxidation of substituted quinolines to produce substituted-pyridine-2,3-dicarboxylic acids |
| 04/01/2001 | CA2321324A1 Quinolin-4yl derivatives |
| 03/29/2001 | WO2001021584A1 Tyrosine derivatives |
| 03/29/2001 | WO2001021577A2 Melanin concentrating hormone antagonist |
| 03/29/2001 | WO2001021160A2 Carboxymide and aniline derivatives as selective inhibitors of pathogens |
| 03/29/2001 | WO2000059875A3 Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 03/29/2001 | CA2386474A1 Melanin concentrating hormone antagonist |
| 03/28/2001 | EP1086093A1 Tetrahydroquinoline derivatives as glycine antagonists |
| 03/28/2001 | EP1086079A1 Derivatives of hydroxyphenylsulfanylbenzoic and hydroxyphenylsulfanylarylacetic acids |
| 03/28/2001 | EP1086078A1 Neuropeptide y5 receptor antagonists |
| 03/28/2001 | EP1086065A4 Combinatorial synthesis of multibinding libraries |
| 03/28/2001 | EP1086065A1 Combinatorial synthesis of multibinding libraries |
| 03/28/2001 | EP1085895A1 Bradykinin antagonists |
| 03/28/2001 | EP1085894A1 Beta 3-adrenergic receptor agonists |
| 03/28/2001 | EP1085893A1 Phosphodiesterase-v modulator drugs and their uses |
| 03/28/2001 | EP1085891A1 Multibinding inhibitors of topoisomerase |
| 03/28/2001 | EP1085889A2 Novel therapeutic agents that modulate endothelin receptors |
| 03/28/2001 | EP1085887A2 Novel angiotensin receptor modulators and their uses |
| 03/28/2001 | EP1085870A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 03/28/2001 | EP1085868A1 H1-histamine receptor antagonists |
| 03/28/2001 | EP1085861A1 Inhibitors of nitric oxide synthase |
| 03/28/2001 | EP1085847A2 Novel therapeutic agents that modulate estrogen receptors |
| 03/28/2001 | EP1085846A2 Multibinding inhibitors of microsomal triglyceride transferase protein |
| 03/28/2001 | EP1085845A2 Multibinding inhibitors of cyclooxygenase-2 |
| 03/28/2001 | EP0876330B1 Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids having retinoid-like biological activity |
| 03/27/2001 | US6207833 Method for the preparation of (2-quinolythio)acetic acid and its hydrochloride |
| 03/27/2001 | US6207693 Benzamide derivatives having a vasopressin antagonistic activity |
| 03/27/2001 | US6207679 Antimicrobial agents uses and compositions related thereto |
| 03/27/2001 | US6207667 1,3 diazines with platelet-derived growth factor receptor inhibitory activity |
| 03/27/2001 | US6207363 Cyan ?nb coupler? |
| 03/22/2001 | WO2001019808A1 Chemical compounds and compositions and their use as cathepsin s inhibitors |
| 03/22/2001 | WO2001019796A1 Compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 03/22/2001 | WO2001019368A1 Quinolinone derivative preparations and process for producing the same |
| 03/22/2001 | WO2000001376A3 Pharmaceutical compositions and their uses for treatment of demyelinating disorders |
| 03/22/2001 | WO1999063936A8 Novel therapeutic agents that modulate endothelin receptors |
| 03/22/2001 | CA2384974A1 Compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 03/21/2001 | EP1085371A1 Photographic material containing a novel hydrazide type |
| 03/21/2001 | EP1085011A1 Novel polyamine analogues as therapeutic and diagnostic agents |
| 03/21/2001 | EP1084110A1 Quinolones used as mrs inhibitors and bactericides |
| 03/21/2001 | EP1083921A1 Novel leukotriene receptor antagonists and their uses |
| 03/21/2001 | EP1083920A1 Novel antibacterial compounds |
| 03/21/2001 | EP1083919A1 Novel antiviral compounds |
| 03/21/2001 | EP1083917A1 Novel analgesic agents |
| 03/21/2001 | EP1083894A1 MULTIBINDING INHIBITORS OF HMG-CoA REDUCTASE |
| 03/21/2001 | EP1083893A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d 1? receptors |
| 03/21/2001 | EP1083888A1 MULTIBINDING AGENTS THAT MODULATE PPARgamma AND RXR RECEPTORS |
| 03/21/2001 | EP0613466B1 Organic compounds |
| 03/21/2001 | CN1063430C Ethanolamine derivatives |
| 03/20/2001 | US6204290 Treating a hypercholesteremic, thrombotic, oxidative, inflammatory, or immunoregulatory disease |
| 03/15/2001 | WO2001018171A2 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof |
| 03/15/2001 | WO2001017982A1 Benzophenones as inhibitors of reverse transcriptase |
| 03/15/2001 | WO2001017968A1 Integrase inhibitors containing aromatic heterocycle derivatives |
| 03/15/2001 | CA2383999A1 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof |
| 03/15/2001 | CA2383782A1 Compounds for the treatment of viral infections |
| 03/15/2001 | CA2318004A1 Novel polyamine analogues as therapeutic and diagnostic agents |
| 03/14/2001 | EP1083166A1 Novel substituted guanidine derivatives and process for producing the same |
| 03/14/2001 | EP1082960A2 Use of CRF antagonists and related compositions for treating depression and modifying the circadian rhytm |
| 03/14/2001 | EP1082310A1 Methods of identifying and using hla binding compounds as hla-agonists and antagonists |
| 03/14/2001 | EP1082308A1 Heterocyclically substituted amides used as calpain inhibitors |
| 03/14/2001 | EP1082289A1 Methods for identifying novel multimeric agents that modulate receptors |